Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Here are comprehensive model answers for your entire Pediatrics First Terminal Examination paper:

DEPARTMENT OF PEDIATRICS - FIRST TERMINAL EXAMINATION (2023 BATCH)

COMPLETE MODEL ANSWERS


SECTION A - LONG ESSAYS (4 x 10 = 40 Marks)


Q1. IMNCI Approach + Assessment, Classification & Management of Cough/Difficulty Breathing

Part 1: IMNCI (Integrated Management of Neonatal and Childhood Illness)

Definition: IMNCI is a WHO/UNICEF strategy for integrated management of sick children aged 0-5 years in first-level health facilities and at community level.
Objectives:
  • Reduce under-5 mortality and morbidity
  • Improve quality of care at home and health facilities
  • Promote healthy growth and development
Components of IMNCI:
  1. Improvements in case management skills of health workers
  2. Improvements in overall health system
  3. Improvements in family and community practices
IMNCI Approach - Steps in Case Management:
  1. Check for danger signs (general danger signs)
  2. Assess main symptoms - Cough/difficulty breathing, diarrhea, fever, ear problem
  3. Check nutritional status - Weight, height, MUAC
  4. Check immunization and Vitamin A status
  5. Assess other problems
  6. Classify illness using color-coded system (Pink/Yellow/Green)
  7. Identify treatment and treat accordingly
  8. Counsel mother
General Danger Signs (IMNCI):
  • Not able to drink or breastfeed
  • Vomiting everything
  • Convulsions (present illness)
  • Lethargic or unconscious

Part 2: Assessment, Classification & Management of Cough/Difficulty Breathing

Assessment:
  • How long has the child had cough?
  • Count respiratory rate for 1 full minute
  • Look for chest indrawing
  • Look and listen for stridor
  • Look and listen for wheeze
Age-specific Fast Breathing Thresholds:
AgeFast Breathing
< 2 months≥ 60 breaths/min
2-12 months≥ 50 breaths/min
1-5 years≥ 40 breaths/min
Classification (Color-coded):
ClassificationSignsTreatment
SEVERE PNEUMONIA (Pink)Chest indrawing OR stridor in calm childRefer URGENTLY; give first dose antibiotic (Ampicillin/Benzylpenicillin); treat fever/wheeze
PNEUMONIA (Yellow)Fast breathing ONLYOral Amoxicillin x 5 days; soothe throat; follow-up 2 days
NO PNEUMONIA - Cough/Cold (Green)No fast breathing, no chest indrawingSoothe throat with safe remedy; if >30 days - refer; follow-up 5 days
Treatment - Pneumonia:
  • Amoxicillin: 40 mg/kg/day in 2 divided doses x 5 days
  • Cotrimoxazole as alternative
  • Treat fever if present (Paracetamol)
  • Treat wheeze if present (bronchodilator)
  • Advise when to return immediately
Antibiotic for Severe Pneumonia:
  • Ampicillin 50 mg/kg IM/IV every 6 hours PLUS Gentamicin 7.5 mg/kg IM/IV once daily

Q2. Protein Energy Malnutrition (PEM) - Definition, SAM Classification, Clinical Features & Management

Definition of PEM

PEM is a spectrum of nutritional disorders resulting from insufficient intake of protein and/or energy to meet physiological needs. It ranges from subclinical deficiency to obvious wasting, stunting, and kwashiorkor.
Types:
  • Marasmus - Deficiency of both protein AND calories
  • Kwashiorkor - Primarily protein deficiency with adequate caloric intake
  • Marasmic-Kwashiorkor - Features of both

Severe Acute Malnutrition (SAM) - Definition

SAM is defined by any one of:
  • Weight-for-height/length < -3 SD (Z-score) of WHO median
  • MUAC < 115 mm (in 6-59 months)
  • Bilateral pitting edema of nutritional origin
  • Visible severe wasting

Clinical Features

Marasmus:
  • Gross wasting of muscle and subcutaneous fat (skin and bones appearance)
  • "Old man face" - sunken cheeks
  • Loose, wrinkled skin - "baggy pants" appearance
  • Marked weight loss (< 60% of expected)
  • Child is alert, hungry, and irritable
  • No edema
  • Hair changes less prominent
  • Voracious appetite
Kwashiorkor:
  • Bilateral pitting pedal edema (cardinal feature)
  • Moon face (due to edema)
  • Flaky paint/crazy pavement dermatosis - skin changes
  • Hair changes: depigmentation (reddish/brownish), easily pluckable, "flag sign"
  • Hepatomegaly (fatty liver)
  • Miserable, anorexic child
  • Low serum albumin
  • May have adequate weight due to edema (masked wasting)

Management of SAM - Ten Steps (WHO)

Phase 1 - Stabilization (Days 1-7):
  1. Treat/prevent hypoglycemia - give glucose orally/NG if unconscious; F-75 diet
  2. Treat/prevent hypothermia - keep warm; Kangaroo mother care
  3. Treat/prevent dehydration - use ReSoMal (not standard ORS); 5 mL/kg every 30 min for 2 hours
  4. Correct electrolyte imbalance - K+, Mg²+ supplementation (avoid Na+)
  5. Treat infection - Broad-spectrum antibiotics (Amoxicillin/Cotrimoxazole); if sick: Ampicillin + Gentamicin
  6. Correct micronutrient deficiencies - Vit A, folic acid, zinc, copper, multivitamin (NO iron in phase 1)
  7. Begin cautious feeding - F-75 formula (75 kcal/100 mL); 100 mL/kg/day; every 2-3 hours
Phase 2 - Rehabilitation (Weeks 2-6): 8. Achieve catch-up growth - F-100 (100 kcal/100 mL); increase to 150-220 mL/kg/day 9. Provide sensory stimulation - play therapy, emotional support 10. Prepare for follow-up after recovery
Ready-to-Use Therapeutic Food (RUTF): Plumpy'nut - used in community-based management
Discharge Criteria: MUAC ≥ 125 mm; no edema x 2 consecutive visits; weight-for-height ≥ -2 SD

Q3. Acute Diarrhea - Etiology, Clinical Features, Complications, Management + ORS & Zinc Therapy

Definition

Passage of ≥ 3 loose/watery stools in 24 hours; acute = < 14 days duration

Etiology

Viral (most common):
  • Rotavirus (most common cause of severe diarrhea in under-5s)
  • Norovirus, Adenovirus, Astrovirus
Bacterial:
  • Escherichia coli (ETEC, EPEC, EAEC)
  • Shigella dysenteriae - dysentery
  • Vibrio cholerae - rice-water stools
  • Campylobacter jejuni
  • Salmonella species
Parasitic:
  • Giardia lamblia
  • Entamoeba histolytica - amoebic dysentery
  • Cryptosporidium

Clinical Features

  • Watery loose stools - frequent (3-10+/day)
  • Nausea, vomiting
  • Abdominal cramps
  • Fever (especially viral/bacterial)
  • Signs of dehydration (see Section C)
  • Blood/mucus in stools (dysentery - bacterial)

Complications

  • Dehydration - most common, life-threatening
  • Electrolyte imbalance (hypo/hypernatremia, hypokalemia)
  • Metabolic acidosis
  • Hypoglycemia (especially in malnourished)
  • Acute kidney injury (prerenal)
  • Malnutrition (prolonged)
  • Intussusception (rare, post-infectious)
  • Hemolytic Uremic Syndrome (ETEC/Shigella)

Management (IMNCI - Plan A/B/C)

Plan A (No dehydration):
  • Continue breastfeeding
  • Give extra fluids (ORS, clean water, soup)
  • Continue feeding
  • Signs to return immediately
  • Zinc supplementation
Plan B (Some dehydration):
  • ORS: 75 mL/kg over 4 hours in clinic
  • Reassess after 4 hours
  • If improved - Plan A; if worsening - Plan C
Plan C (Severe dehydration):
  • IV fluids: Ringer's lactate/Normal saline
  • < 12 months: 30 mL/kg over 1 hour, then 70 mL/kg over 5 hours
  • 12 months: 30 mL/kg over 30 min, then 70 mL/kg over 2.5 hours
  • Reassess every 15-30 min
Antibiotics: Only for dysentery (Ciprofloxacin/Azithromycin), cholera (Doxycycline/Azithromycin), Giardia (Metronidazole)
Antidiarrheals: NOT recommended in children

ORS (Oral Rehydration Solution)

WHO Low-Osmolarity ORS Composition (2002):
ComponentAmount
Sodium chloride2.6 g/L
Glucose (anhydrous)13.5 g/L
Potassium chloride1.5 g/L
Trisodium citrate2.9 g/L
Osmolarity245 mOsm/L
Sodium75 mEq/L
Chloride65 mEq/L
Glucose75 mmol/L
Potassium20 mEq/L
Citrate10 mEq/L
Mechanism: Glucose-coupled sodium cotransport (SGLT1) drives water absorption even during active secretion.
ReSoMal (for SAM): Lower sodium (45 mEq/L), higher potassium, lower osmolarity (300 mOsm/L)

Zinc Therapy

Rationale: Zinc deficiency is common in malnourished children; zinc reduces stool frequency and duration.
Dose:
  • < 6 months: 10 mg/day x 14 days
  • ≥ 6 months: 20 mg/day x 14 days
Benefits:
  • Reduces duration of diarrhea by ~25%
  • Reduces severity (stool frequency and volume)
  • Prevents subsequent episodes for 2-3 months
  • Reduces risk of progression to persistent diarrhea

Q4. Measles - Etiology, Clinical Features, Diagnosis, Complications & Management

Etiology

  • Causative agent: Measles virus - RNA virus, paramyxovirus family (genus Morbillivirus)
  • Transmission: Droplet infection; highly contagious (R₀ = 12-18)
  • Incubation period: 10-14 days (range 7-18 days)
  • Infectious period: 4 days before to 4 days after rash appearance
  • Epidemic pattern: Winter-spring; 2-yearly cycles

Clinical Features

Prodromal Stage (Day 1-4):
  • High fever (38-40°C)
  • Coryza (runny nose)
  • Cough (barking)
  • Conjunctivitis (3 Cs: Cough, Coryza, Conjunctivitis)
  • Koplik's spots (pathognomonic) - Appear on Day 2-3; salt/sand grains on a red base on buccal mucosa opposite lower molars; disappear 1-2 days after rash
Eruptive Stage (Day 4 onwards):
  • Rash: Maculopapular, starts behind ears/hairline; spreads downward (cephalocaudal) over 3 days: face → trunk → limbs
  • Fever peaks with rash, then falls
  • Rash lasts 4-7 days; fades in same order it appeared
  • Post-measles desquamation and brownish staining

Diagnosis

  • Mainly clinical (Koplik's spots + typical rash)
  • Serology: IgM antibody (positive 3-4 days after rash onset) - confirmatory
  • Viral isolation/PCR (epidemiological purposes)

Complications

Respiratory:
  • Pneumonia (most common cause of death) - measles giant cell pneumonitis, secondary bacterial pneumonia
  • Croup (laryngitis)
  • Otitis media (most common complication overall)
Neurological:
  • Acute post-measles encephalitis (1/1000 cases) - day 2-5 after rash
  • Febrile seizures
  • Subacute sclerosing panencephalitis (SSPE) - rare, fatal; 7-10 years after infection; caused by defective measles virus
Others:
  • Diarrhea and vomiting
  • Keratoconjunctivitis → corneal ulceration → blindness (especially with Vit A deficiency)
  • Cancrum oris (noma) - in severely malnourished
  • Myocarditis, hepatitis (rare)

Management

Supportive:
  • Antipyretics (Paracetamol)
  • Adequate hydration and nutrition
  • Continue breastfeeding
Vitamin A: (Reduces mortality by 50%)
  • < 6 months: 50,000 IU single dose
  • 6-12 months: 100,000 IU single dose
  • 12 months: 200,000 IU single dose
  • Repeat if signs of Vit A deficiency (xerophthalmia)
Antibiotics: Only if secondary bacterial infection (otitis media, pneumonia)
Complications: Treat accordingly
Prevention:
  • MMR vaccine at 9 months (NIS - India: MR at 9-12 months) and 15-18 months booster
  • Post-exposure prophylaxis: Vaccine within 72 hours OR immunoglobulin within 6 days

SECTION B - SHORT ESSAYS (6 x 5 = 30 Marks)


B-Q1. National Immunization Schedule (NIS) - India

VaccineAgeRoute/SiteDose
BCG + OPV-0 + Hep B-1BirthID (right arm) / Oral / IM0.1 mL / 2 drops / 0.5 mL
OPV-1 + Pentavalent-1 + RVV-1 + fIPV-16 weeksOral / IM (left thigh) / Oral / ID (right arm)
OPV-2 + Pentavalent-2 + RVV-210 weeks
OPV-3 + Pentavalent-3 + fIPV-2 + RVV-314 weeks
MR-1 + PCV-1 + JE-1 (endemic areas)9-12 monthsSC / IM / SC0.5 mL each
MR-2 + DPT-B1 + OPV-B1 + PCV-B + JE-2 + Vitamin A (1st dose)16-24 months
DPT-B2 + OPV-B2 + Vitamin A (2nd-9th dose)5-6 yearsIM / OralEvery 6 months
Td10 years, 16 yearsIM0.5 mL
TT/TdPregnancy (TT-1, TT-2/Booster)IM0.5 mL
Pentavalent = DPT + Hep B + Hib
Cold chain: Vaccines require 2-8°C storage (except OPV: -15 to -25°C; BCG: 2-8°C)

B-Q2. Breastfeeding - Advantages and Exclusive Breastfeeding

Definition of Exclusive Breastfeeding (EBF)

Feeding only breast milk - no other food, water, or liquid (except medications/vitamins/minerals) for the first 6 months of life.

Advantages of Breastfeeding

For Infant:
  • Nutritional: Perfect composition; bioavailability of iron, zinc, calcium superior; composition changes with infant's needs
  • Immunological: IgA (secretory), lactoferrin, lysozyme, macrophages - protection against infections
  • Reduces incidence/severity of diarrhea, pneumonia, otitis media, UTI, meningitis
  • Reduces risk of SIDS, childhood obesity, type 1 DM, allergies, leukemia
  • Promotes bonding, cognitive development (DHA in breast milk)
  • Perfect temperature, sterile, convenient, no preparation
For Mother:
  • Uterine involution (oxytocin release) - reduces postpartum hemorrhage
  • Lactational amenorrhea - natural contraception (LAM: <6 months, EBF, amenorrheic = 98% effective)
  • Reduced risk of breast and ovarian cancer
  • Faster return to pre-pregnancy weight (burns ~500 kcal/day)
  • Psychological bonding/satisfaction
  • Cost-effective (no formula cost)
WHO Recommendation: EBF for 6 months, then complementary feeding with continued breastfeeding up to 2 years or beyond.
Contraindications to Breastfeeding:
  • HIV positive mother (in developed countries)
  • Active untreated tuberculosis
  • Galactosemia (infant)
  • Maternal chemotherapy/radiotherapy
  • Herpes simplex lesions on nipple

B-Q3. Vitamin A Deficiency - Clinical Features and Prevention

Vitamin A Deficiency (VAD)

Causes: Inadequate dietary intake, malabsorption (fat malabsorption), measles (precipitant), protein deficiency

Clinical Features - Bitot's WHO Classification (XN to XF)

StageFeatures
XNNight blindness (nyctalopia) - earliest symptom
X1AConjunctival xerosis (dry, lustreless conjunctiva)
X1BBitot's spots - Triangular, foamy/cheesy plaques on temporal conjunctiva (pathognomonic)
X2Corneal xerosis - hazy, lustreless cornea
X3ACorneal ulceration < 1/3 corneal surface
X3BKeratomalacia - ulceration > 1/3 corneal surface; total liquefaction → blindness (most severe)
XFXerophthalmia fundus - white dots peripheral retina
XSCorneal scar (sequela)
Systemic features:
  • Follicular hyperkeratosis (toad skin)
  • Increased susceptibility to infections (measles, diarrhea, respiratory)
  • Growth retardation
  • Anemia (impairs iron utilization)

Prevention

Dietary: Dark green leafy vegetables, yellow/orange fruits (mango, papaya), egg yolk, liver, milk, fish
National Vitamin A Supplementation Programme (India):
  • 9-12 months: 1st dose with MR vaccine - 1 lakh IU
  • 16-24 months to 5 years: 2 lakh IU every 6 months (total 9 doses)
Treatment:
  • Day 1, Day 2, Day 8 (or 4 weeks later) - age-specific doses
  • 12 months: 200,000 IU per dose
Fortification: Fortify edible oils, sugar, milk with Vitamin A

B-Q4. Rickets - Etiology, Clinical Features and Treatment

Definition

Failure of mineralization of growing bone/osteoid at the growth plate due to deficiency of Vitamin D, calcium, or phosphorus.

Etiology

Nutritional Rickets (most common):
  • Vitamin D deficiency (dietary lack + inadequate sunlight)
  • Calcium deficiency rickets (common in Africa/India - low calcium diet)
Malabsorption: Celiac disease, inflammatory bowel disease, cholestatic liver disease
Renal Rickets: Chronic kidney disease (renal osteodystrophy), Fanconi syndrome
Vitamin D-dependent Rickets (VDDR): Type I (1-alpha hydroxylase deficiency), Type II (receptor defect)
Hypophosphatemic Rickets (X-linked): Phosphate wasting at renal tubule

Clinical Features

Skeletal:
  • Craniotabes - softening of skull bones (earliest sign, <6 months)
  • Delayed anterior fontanelle closure
  • Frontal bossing (hot cross bun skull)
  • Rachitic rosary - beading of costochondral junctions
  • Harrison's sulcus - horizontal groove on lower chest (pull of diaphragm)
  • Pigeon chest (pectus carinatum) or Harrison's groove
  • Bow legs (genu varum) - most common; or knock knees (genu valgum) after walking
  • Metaphyseal widening - wrist widening (most common clinical site seen)
  • Delayed teething, enamel defects
  • Short stature
Non-skeletal:
  • Hypocalcemic features: Tetany, seizures, stridor (laryngospasm), Chvostek's sign, Trousseau's sign
  • Hypotonia, pot belly
  • Anemia, susceptibility to infections

Investigations

  • X-ray wrist: Cupping, fraying, splaying of metaphysis; widened growth plate (most characteristic)
  • Serum 25-OHD3 < 20 ng/mL (deficiency), < 12 ng/mL (severe)
  • Low/normal calcium, low phosphorus, elevated ALP (markedly)
  • PTH elevated (secondary hyperparathyroidism)

Treatment

Vitamin D deficiency rickets:
  • Stoss therapy: Single oral dose of 3-6 lakh IU Vitamin D - preferred
  • Daily therapy: 2000-4000 IU/day for 3 months
  • Calcium supplementation: 500-1000 mg/day
  • Adequate sunlight (30 min/day of face/arm exposure)
Monitoring: X-ray, ALP at 3 months (healing: ALP normalizes first)
Hypophosphatemic rickets: Phosphate + calcitriol supplementation

B-Q5. Dengue Fever - Warning Signs and Management

Dengue Fever

Causative agent: Dengue virus (DENV 1-4) - Flavivirus; transmitted by Aedes aegypti mosquito

WHO 2009 Classification

  1. Dengue without warning signs
  2. Dengue with warning signs
  3. Severe dengue

Warning Signs (W in Dengue)

Appear during defervescence (day 3-7), as fever resolves:
  1. Abdominal pain - severe, continuous
  2. Persistent vomiting (≥ 3 in 24 hours)
  3. Clinical fluid accumulation - pleural effusion, ascites
  4. Mucosal bleed - gum bleeding, epistaxis
  5. Lethargy/restlessness
  6. Liver enlargement > 2 cm
  7. Rise in HCT with rapid decrease in platelet count

Severe Dengue (any one):

  • Severe plasma leakage → dengue shock syndrome (DSS) → circulatory failure
  • Severe bleeding
  • Severe organ involvement (liver: AST/ALT ≥ 1000, CNS: altered consciousness, heart, kidneys)

Management

Group A (Dengue without warning signs - outpatient):
  • Adequate oral hydration (ORS, coconut water, juice)
  • Paracetamol (NOT aspirin or ibuprofen - risk of bleeding)
  • Antipyretics, mosquito net
  • Daily monitoring
Group B (Dengue with warning signs - hospitalize):
  • IV crystalloids (NS/RL): 5-10 mL/kg/hour initially
  • Titrate based on clinical response; monitor HCT, urine output
  • Platelet transfusion: Only if < 10,000/µL (no active bleeding) or < 20,000/µL with bleeding
  • Monitor every 1-2 hours
Group C (Severe dengue - ICU):
  • IV fluid resuscitation: 20 mL/kg bolus over 15-30 min
  • Colloids (gelatin/dextran) if HCT still rising despite crystalloids
  • Blood transfusion for severe hemorrhage
  • Vasopressors if refractory shock
  • Organ support as needed
No specific antiviral therapy available.

B-Q6. Rules of Development and Factors Affecting Development

Normal Development - Key Rules

  1. Cephalocaudal progression - Head control before sitting before standing
  2. Proximal to distal - Shoulder control before hand, hand before finger grasp
  3. General to specific - Mass movements before fine movements
  4. Sequential and predictable - Fixed sequence (though rate varies)
  5. Continuous process - Never stops throughout life
  6. Rate varies between children - Normal variation exists around milestones
  7. Bilateral to unilateral - Bilateral movements before dominant hand preference
  8. Integration of primitive reflexes allows voluntary movements
  9. Development reflects maturation of CNS - myelination pattern

Key Developmental Milestones (Summary)

AgeGross MotorFine MotorLanguageSocial
3 monthsHead controlOpen fistsCoosSocial smile
6 monthsSits with supportPalmar graspBabblesStranger anxiety begins
9 monthsSits without supportPincer (immature)Mama/Dada (non-specific)Peek-a-boo
12 monthsWalks with supportMature pincer1 word with meaningWaves bye
18 monthsWalks wellScribbles10 wordsPoints to wants
2 yearsRuns, up stairsTower of 6 cubes2-word sentencesParallel play
3 yearsTricycleTower of 9, copies circle3-word sentences, 900 wordsGroup play
5 yearsSkipsTies shoelace, copies triangleFluent speechCooperative play

Factors Affecting Development

Biological/Intrinsic Factors:
  • Genetics/heredity
  • Gestational age (prematurity)
  • Birth weight
  • Nutrition (especially first 1000 days)
  • Hormones (thyroid, growth hormone)
  • Sensory integrity (hearing, vision)
  • CNS integrity (birth asphyxia, meningitis, trauma)
Environmental/Extrinsic Factors:
  • Socioeconomic status
  • Parental education and stimulation
  • Quality of caregiver interaction (attachment)
  • Play opportunities and toys
  • School and peer influence
  • Infections, toxin exposure (lead)
  • Psychosocial adversity, abuse, neglect

SECTION C - SHORT ANSWERS (10 x 3 = 30 Marks)


C-Q1. DANGER Signs in a Sick Child (IMNCI General Danger Signs)

  1. Not able to drink or breastfeed
  2. Vomits everything
  3. History of convulsions during present illness
  4. Lethargic or unconscious
Plus age-specific signs for young infant (< 2 months):
  • Axillary temperature < 35.5°C or > 37.5°C
  • Severe chest indrawing
  • Nasal flaring
  • Bulging fontanelle
  • Umbilical discharge/redness extending to skin
Any general danger sign = Refer URGENTLY to hospital

C-Q2. Fever with Rash

ConditionRash CharacterDistributionKey Feature
MeaslesMaculopapular, redCephalocaudal (face→feet)Koplik's spots, 3 Cs
RubellaFine maculopapular, pinkFace→trunk→limbs (faster, 3 days)Forchheimer spots, posterior cervical LAP
ChickenpoxVesicular - "dewdrop on rose petal"Centripetal (trunk more than limbs)All stages simultaneously, pruritic
Roseola Infantum (HHV-6)Macular, rose-coloredTrunk → limbsRash AFTER fever resolves (rose spots)
Scarlet FeverSandpaper rash, erythematousNeck→trunk (spares face)Circumoral pallor, strawberry tongue
DengueMaculopapular + petechiaeTrunk; Islands of white in sea of redTourniquet test positive
MeningococcemiaPetechiae/purpura, non-blanchingWidespreadRapidly progressing - EMERGENCY
TyphoidRose spots (2-4 mm)Trunk7-10 day fever before rash
KawasakiPolymorphousTrunk, perineumFever > 5 days + 4/5 criteria

C-Q3. Types of Vaccines

Based on Composition:

1. Live Attenuated Vaccines:
  • Weakened live organism
  • Single dose usually sufficient; produces cellular + humoral immunity
  • Examples: BCG, OPV, MMR, Varicella, Yellow Fever, Rotavirus
  • Contraindicated in immunocompromised
2. Killed/Inactivated Vaccines:
  • Whole killed organism
  • Multiple doses needed; less durable immunity
  • Examples: IPV (Salk), Hepatitis A, Rabies, Pertussis (whole cell), JE
3. Toxoid Vaccines:
  • Inactivated bacterial toxin
  • Examples: Diphtheria toxoid, Tetanus toxoid (DT, Td, TT)
4. Subunit/Acellular Vaccines:
  • Purified antigen component
  • Examples: Acellular pertussis (DTaP), Hepatitis B (surface antigen), Typhoid Vi polysaccharide
5. Conjugate Vaccines:
  • Polysaccharide antigen linked to protein carrier → T-dependent response
  • Examples: Hib, Pneumococcal (PCV), Meningococcal
6. Recombinant Vaccines:
  • Produced by genetic engineering
  • Example: Hepatitis B (HBsAg in yeast)
7. mRNA Vaccines:
  • Example: COVID-19 vaccines (Pfizer-BioNTech, Moderna)

C-Q4. Signs of Dehydration

FeatureNo DehydrationSome DehydrationSevere Dehydration
General conditionWell, alertRestless, irritableLethargic/unconscious
EyesNormalSunkenVery sunken, dry
TearsPresentAbsentAbsent
Mouth/tongueMoistDryVery dry
ThirstDrinks normallyThirsty, drinks eagerlyDrinks poorly/not at all
Skin pinchGoes back immediatelyGoes back slowly (< 2 sec)Goes back very slowly (> 2 sec)
FontanelleNormalSlightly sunkenMarkedly sunken
UrineNormalDecreased, concentratedOliguria/anuria
PulseNormalSlightly rapidRapid, feeble or impalpable
BPNormalNormal/lowHypotension
% Fluid deficit< 5%5-9%≥ 10%

C-Q5. ORS Composition

WHO Low-Osmolarity ORS (2002 - currently recommended):
ComponentConcentration (mmol/L)Grams/Litre
Sodium75-
Chloride65NaCl: 2.6 g
Glucose (anhydrous)7513.5 g
Potassium20KCl: 1.5 g
Citrate10Sodium citrate: 2.9 g
Total osmolarity245 mOsm/L-
How to prepare: Dissolve one ORS sachet in 1 litre of clean water
Advantages of reduced-osmolarity ORS over old ORS (311 mOsm/L):
  • Less stool output
  • Less vomiting
  • Reduced need for IV therapy
  • Safer in children

C-Q6. Difference Between Marasmus and Kwashiorkor

FeatureMarasmusKwashiorkor
DefinitionDeficiency of protein + caloriesPrimarily protein deficiency
Age< 1 year (infants)1-3 years (toddlers)
CauseStarvation (early weaning, no breastfeeding)Protein-poor diet (after weaning on starchy food)
Weight< 60% expected; markedly reduced60-80% expected; may be normal (edema masks)
EdemaAbsentPresent (bilateral, pitting, pedal)
FaceOld man face, sunken cheeksMoon face (edema)
MuscleGrossly wastedWasted (masked by edema)
Subcutaneous fatAbsentPresent (variable)
SkinLoose, wrinkled, baggy pantsFlaky paint dermatosis, hyperpigmentation
HairSparse, thinDepigmented, easily pluckable, flag sign
LiverNormalHepatomegaly (fatty liver)
AppetiteVoracious (hungry)Anorexic, miserable
MoodAlert, irritableApathetic, miserable
Serum albuminLow-normalVery low
PrognosisBetterWorse (more complications)

C-Q7. Triad of Congenital Rubella Syndrome (Gregg's Triad)

Gregg's Triad:
  1. Congenital Heart Disease - Patent Ductus Arteriosus (PDA) most common; also pulmonary artery stenosis, VSD, ASD
  2. Congenital Cataracts - "Salt and pepper" retinopathy; may have glaucoma; "pearly white" lens opacity
  3. Sensorineural Hearing Loss - Most common single defect; bilateral, often severe
Additional features of Congenital Rubella Syndrome (CRS):
  • Blueberry muffin spots (dermal hematopoiesis)
  • Microcephaly, mental retardation
  • Thrombocytopenic purpura
  • Hepatosplenomegaly
  • Growth retardation
  • Diabetes mellitus (late)
  • Thyroid dysfunction (late)
Risk of CRS: Highest if maternal infection in first trimester (up to 85% risk in first 8 weeks)
Prevention: MMR vaccination before pregnancy; rubella IgM serology in early pregnancy

C-Q8. Complications of Diphtheria

Causative agent: Corynebacterium diphtheriae (toxin-mediated disease)

Complications (Local and Systemic):

Respiratory/Local:
  • Airway obstruction - most common cause of death; membrane spreads to larynx → "bull neck", croup, stridor
  • Aspiration pneumonia
  • Tracheitis, bronchitis
Cardiovascular (Myocarditis):
  • Most important cause of death (late complication, weeks 2-3)
  • ECG: ST changes, heart block (all degrees), ventricular arrhythmias, complete AV block
  • Myocarditis occurs in 10-25% of cases
  • Dilated cardiomyopathy, heart failure
Neurological:
  • Palatal palsy - earliest, 1-2 weeks (nasal twang, regurgitation)
  • Oculomotor palsy - diplopia, blurred vision, ptosis (3-5 weeks)
  • Peripheral neuropathy - ascending polyneuropathy, months after illness (Guillain-Barré like)
  • Phrenic nerve palsy → diaphragmatic paralysis → respiratory failure
Other:
  • Thrombocytopenia
  • Renal tubular necrosis
  • Adrenal hemorrhage

C-Q9. Define Cold Chain

Cold Chain is the system of transporting and storing vaccines at the manufacturer-recommended temperature (2-8°C for most vaccines) from the point of manufacture to the point of administration to maintain potency (viability) of vaccines.
Components of Cold Chain:
  1. Cold chain equipment:
  • ILR (Ice-lined refrigerators) - District/PHC level
  • Deep freezer (-15 to -25°C) - for OPV storage
  • Cold boxes - for transportation
  • Vaccine carriers - for last mile (field level)
  • Ice packs
  1. Cold chain personnel: Trained handlers at each level
  2. Cold chain transportation: Insulated vans, cold boxes
  3. Cold chain monitoring:
  • VVM (Vaccine Vial Monitor) - heat-sensitive label on vial; inner square becomes darker than outer ring when vaccine is heat-damaged
  • Thermometer logs
  • Shake test (for freeze-sensitive vaccines like DPT, Hep B, TT)
Cold Chain Levels in India:
  • National/Regional: Vaccine manufacturers → national stores
  • State → District (ILR + deep freezer)
  • Taluk/Block (PHC) - ILR + deep freezer
  • Sub-centre/field - vaccine carrier with ice packs
"Open Vial Policy": Multi-dose vials (OPV, BCG, Measles) can be reused at subsequent sessions if stored at 2-8°C

C-Q10. Causes of Iron Deficiency Anemia (IDA)

Most common cause of anemia worldwide, especially in children 6 months-2 years

Causes:

1. Inadequate Intake:
  • Exclusive breastfeeding beyond 6 months without complementary foods
  • Cow's milk diet (low iron, high calcium blocks absorption)
  • Poor weaning diet (cereal-based, low meat/flesh foods)
  • Poverty, food insecurity
2. Increased Demand:
  • Prematurity/low birth weight (reduced iron stores at birth)
  • Rapid growth (infancy, adolescence)
  • Twin pregnancy
3. Decreased Absorption:
  • Malabsorption syndromes (celiac disease, short bowel)
  • Achlorhydria (reduced ferric → ferrous conversion)
  • Inhibitors in diet: phytates (cereals), tannins (tea), calcium (dairy) - taken with iron
  • Helicobacter pylori infection (reduces absorption)
4. Increased Loss:
  • Chronic blood loss: Hookworm infestation (most common cause in older children/adults in India)
  • Meckel's diverticulum, intestinal polyps
  • Cow's milk protein-induced enteropathy (occult blood loss)
  • Inflammatory bowel disease
  • Repeated phlebotomy
5. Perinatal Causes:
  • Early cord clamping (reduces iron transfer)
  • Feto-maternal hemorrhage
  • Small for gestational age
Investigation: Blood picture (microcytic hypochromic), low serum ferritin (most sensitive), low serum iron, raised TIBC, low transferrin saturation, low reticulocyte count

All answers are based on standard pediatric references including Nelson's Textbook of Pediatrics, IAP Textbook of Pediatrics, WHO/UNICEF IMNCI guidelines, and National Health Mission (India) protocols.
This is a shared conversation. Sign in to Orris to start your own chat.